Latest news
Latigo Biotherapeutics, Clinical-Stage Developer of Selective Nav1.8 Non‑Opioid Pain Medicines for Acute and Chronic Pain, Files for Nasdaq Global Select Market IPO - tradingview.comtradingview.com · Fri, 07 Aug 2026 20:39:00 GMTBlossomHill Therapeutics, Clinical-Stage Oncology Drug Developer, Files for Nasdaq Global Select Market IPO - tradingview.comtradingview.com · Fri, 07 Aug 2026 20:09:00 GMTAnavex Life Sciences (NASDAQ:AVXL) Rallies Today on clinical-stage momentum - Kalkine MediaKalkine Media · Thu, 06 Aug 2026 20:20:00 GMTFrontend development process: The 2026 stage-by-stage guide - NetguruNetguru · Tue, 28 Jul 2026 12:16:28 GMT